Abbott, AbbVie To Pay $25M To Resolve Kickback, Off-Label False Claims Case

(October 29, 2018, 11:24 AM EDT) -- PHILADELPHIA — Abbott Laboratories and spinoff AbbVie Inc. have agreed to pay $25 million to resolve a False Claims Act, 31 U.S. Code § 3729, lawsuit that they paid doctors kickbacks and engaged in off-label marketing of their cholesterol drug TriCor, the U.S. Attorney’s Office for the Eastern District of Pennsylvania announced Oct. 26 (United States ex rel. Amy Bergman, et al. v. Abbott Laboratories, No. 09-4264, E.D. Pa.)....

Attached Documents

Related Sections